Design of Nanodrugs

To date, various nanodrug systems have been developed for different routes of administration, which include dendrimers, nanocrystals, emulsions, liposomes, solid lipid nanoparticles, micelles, and polymeric nanoparticles. Nanodrug systems have been employed to improve the efficacy, safety, physicochemical properties, and pharmacokinetic/pharmacodynamic profile of pharmaceutical substances. In particular, functionalized nanodrug systems can offer enhanced bioavailability of orally taken drugs, prolonged half-life of injected drugs (by reducing immunogenicity), and targeted delivery to specific tissues. Thus, nanodrug systems might lower the frequency of administration while providing maximized pharmacological effects and minimized systemic side effects, possibly leading to better therapeutic compliance and clinical outcomes. In spite of these attractive pharmacokinetic advantages, recent attention has been drawn to the toxic potential of nanodrugs since they often exhibit in vitro and in vivo cytotoxicity, oxidative stress, inflammation, and genotoxicity.

  • Nano sized drugs
  • Novel drugs to nano drugs
  • Nanodrugs for cancer therapy
  • Nanodrugs for medical applications
  • Nanodrugs for veterinary therapeutics

Related Conference of Design of Nanodrugs

April 11-12, 2024

41th Global Nanotechnology Congress

Amsterdam, Netherlands
April 25-26, 2024

36th Nano Congress for Future Advancements

London, UK
May 16-17, 2024

27th World Nanotechnology Congress

Rome, Italy

Design of Nanodrugs Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in